| P2093 | author name string | James A Cowan | |
| | Lalintip Hocharoen | |
| P2860 | cites work | Crystal structure of the human angiotensin-converting enzyme-lisinopril complex | Q24293072 |
| | Catalytic and inhibitor-binding properties of some active-site mutants of human carbonic anhydrase I | Q24318812 |
| | Crystal structures of alpha-mercaptoacyldipeptides in the thermolysin active site: structural parameters for a Zn monodentation or bidentation in metalloendopeptidases | Q27619771 |
| | Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme | Q27730724 |
| | Alpha helix-RNA major groove recognition in an HIV-1 rev peptide-RRE RNA complex | Q27733230 |
| | Carbonic anhydrase inhibitors | Q28219057 |
| | Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences | Q28271771 |
| | Structure of thermolysin refined at 1.6 A resolution | Q28279663 |
| | Targeted cleavage of HIV rev response element RNA by metallopeptide complexes | Q28290700 |
| | Mass spectrometry in viral proteomics. | Q30326412 |
| | High sensitivity of Zn2+ insulin to metal-catalyzed oxidation: detection of 2-oxo-histidine by tandem mass spectrometry | Q30733698 |
| | Palladium(II) complex as a sequence-specific peptidase: hydrolytic cleavage under mild conditions of X-Pro peptide bonds in X-Pro-Met and X-Pro-His segments | Q30761534 |
| | Protein-cleaving catalyst selective for protein substrate | Q31118066 |
| | Peptide-cleaving catalyst selective for peptide deformylase | Q31149040 |
| | Hydroxyl radical footprinting of proteins using metal ion complexes | Q31873275 |
| | Artificial metalloprotease with active site comprising aldehyde group and Cu(II)cyclen complex | Q33218125 |
| | Metal complexes as artificial proteases: toward catalytic drugs | Q33318990 |
| | Cleavage agents for soluble oligomers of human islet amyloid polypeptide | Q33322548 |
| | Characterization of Copper(III)-Tetrapeptide Complexes with Histidine as the Third Residue | Q34098779 |
| | Antioxidants and protein oxidation. | Q34146666 |
| | Substitution of potential metal-coordinating amino acid residues in the zinc-binding site of endopeptidase-24.11. | Q34334996 |
| | Chemical nucleases | Q34459868 |
| | Synthetic artificial peptidases and nucleases using macromolecular catalytic systems | Q35177330 |
| | A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors | Q36545053 |
| | Catalytic organometallic anticancer complexes | Q36823229 |
| | Ascorbic acid and oxidative inactivation of proteins | Q37558999 |
| | Transfer of oxygen from an artificial protease to peptide carbon during proteolysis | Q37631018 |
| | Interaction of Cu(II)-Arg-Gly-His-Xaa metallopeptides with DNA: effect of C-terminal residues, Leu and Glu. | Q38357867 |
| | Recent developments in the design of angiotensin-converting enzyme inhibitors | Q39497847 |
| | Zinc metallopeptidases: active site structure and design of selective and mixed inhibitors: new approaches in the search for analgesics and anti-hypertensives | Q40773739 |
| | The metal-catalyzed oxidation of methionine in peptides by Fenton systems involves two consecutive one-electron oxidation processes | Q43812544 |
| | Characterization of the metal-binding site of bovine growth hormone through site-specific metal-catalyzed oxidation and high-performance liquid chromatography-tandem mass spectrometry | Q43846447 |
| | Site-specific oxidation of angiotensin I by copper(II) and L-ascorbate: conversion of histidine residues to 2-imidazolones | Q44119010 |
| | Metal catalyzed oxidation of tyrosine residues by different oxidation systems of copper/hydrogen peroxide | Q44682705 |
| | QSAR studies on benzene sulfonamide carbonic anhydrase inhibitors: need of hydrophobic parameter for topological modeling of binding constants of sulfonamides to human CA-II. | Q45248218 |
| | Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II. | Q46394283 |
| | Hydrolytic protein cleavage mediated by unusual mononuclear copper(II) complexes: X-ray structures and solution studies | Q46461979 |
| | DNA cleavage by copper-ATCUN complexes. Factors influencing cleavage mechanism and linearization of dsDNA. | Q46532506 |
| | Cellular activity of Rev response element RNA targeting metallopeptides. | Q50693753 |
| | Oxygen effect in the radiolysis of proteins. Part 2. Bovine serum albumin. | Q50923509 |
| | A peptide molecule mimicking the copper(II) transport site of human serum albumin. A comparative study between the synthetic site and albumin. | Q52894094 |
| | Cleavage agents for soluble oligomers of amyloid beta peptides. | Q53533591 |
| | Letter: The stabilization of trivalent nickel in deprotonated-peptide complexes | Q67739867 |
| | Fenton chemistry. Amino acid oxidation | Q67976625 |
| | Highly specific oxidative cross-linking of proteins mediated by a nickel-peptide complex | Q72159566 |
| | Catalytic hydrolysis of peptides by cerium(IV) | Q73320288 |
| | Mechanisms of metal-catalyzed oxidation of histidine to 2-oxo-histidine in peptides and proteins | Q73524704 |
| | In vivo cleavage of a target RNA by copper kanamycin A. Direct observation by a fluorescence assay | Q74468199 |
| | Selective recognition and cleavage of RNA loop structures by Ni(II).Xaa-Gly-His metallopeptides | Q77182686 |
| | Metallopeptide-promoted inactivation of angiotensin-converting enzyme and endothelin-converting enzyme 1: Toward dual-action therapeutics | Q80014951 |
| | Stimulation and oxidative catalytic inactivation of thermolysin by copper.Cys-Gly-His-Lys | Q80585450 |
| | Catalytic inactivation of human carbonic anhydrase I by a metallopeptide-sulfonamide conjugate is mediated by oxidation of active site residues | Q80636715 |
| | Inactivation of human angiotensin converting enzyme by copper peptide complexes containing ATCUN motifs | Q81551559 |
| P433 | issue | 35 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8670-8676 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Chemistry—A European Journal | Q898737 |
| P1476 | title | Metallotherapeutics: novel strategies in drug design | |
| P478 | volume | 15 | |